Clinical Trial Update: Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the drug interaction between a daclatasvir/asunaprevir/BMS-791325 combination and rosuvastatin in Hepatitis C patients; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)
• BMS-791325
• Daklinza (Daclatasvir)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED